List of articles in "Drug" category - Page 57

1-(4-(Trifluoromethyl)phenyl)piperazine (pTFMPP) is a serotonergic releasing agent. It is rarely encountered as a designer drug but is much less common than the normal isomer meta-TFMPP.

HU-345 (cannabinol quinone) is a drug that is able to inhibit aortic ring angiogenesis more potently than its parent compound cannabinol.

HU-336 is a strongly antiangiogenic compound significantly inhibiting angiogenesis at concentrations as low as 300nM. It inhibits angiogenesis by directly inducing apoptosis of vascular endothelial cells without changing the expression […]

HU-320 is a drug related to cannabidiol which has strong antiinflammatory and immunosuppressive properties while demonstrating no psychoactive effects.

Tilmacoxib or JTE-522 is a COX-2 inhibitor and is an effective chemopreventive agent against rat experimental liver fibrosis.

Galeterone (TOK-001 or VN/124-1) is an experimental drug being developed by Tokai Pharmaceuticals Inc. for the treatment of prostate cancer. It is both an androgen receptor antagonist and CYP17A1 inhibitor. […]

PF-184563 is a potent selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich Kent research center as a potential treatment for dysmenorrhoea an […]

Fluperlapine (NB 106-689) also known as fluoroperlapine is a tricyclic atypical antipsychotic with additional antidepressant and sedative effects.

Yttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody designed for the treatment of pancreatic cancer. The antibody itself clivatuzumab is conjugated with tetraxetan a chelator for […]

Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio an international public-private consortium with the participation […]